GFAP and myeloid sarcoma: Other cytoskeletal biomarkers: In addition to neurofilaments, other components of the axonal cytoskeleton or other CNS cytoskeletal proteins have been proposed as biomarkers in MS, namely tau protein and glial fibrillary acidic protein (GFAP).